Cargando…
An integrated valuation model for payer and investor
BACKGROUND: In order to optimize positioning and associated drug price for both payer and investor, it is for a company essential to forecast the potential market access attractiveness for the new drug for different indications at the early onset of the clinical development program. This analysis mu...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Routledge
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9176355/ https://www.ncbi.nlm.nih.gov/pubmed/35693380 http://dx.doi.org/10.1080/20016689.2022.2080631 |